Terms: = Breast cancer AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2 AND Prognosis
41 results:
1. Prognostic Worth of nrf2/BACH1/HO-1 Protein Expression in the Development of breast cancer.
Barnes P; Agbo E; Wang J; Amoani B; Kwaku Opoku Y; Okyere P; Saahene RO
Med Princ Pract; 2023; 32(6):369-378. PubMed ID: 37827129
[TBL] [Abstract] [Full Text] [Related]
2. Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis.
Gerratana L; Davis AA; Velimirovic M; Clifton K; Hensing WL; Shah AN; Dai CS; Reduzzi C; D'Amico P; Wehbe F; Medford A; Wander SA; Gradishar WJ; Behdad A; Puglisi F; Ma CX; Bardia A; Cristofanilli M
Breast Cancer Res; 2023 Oct; 25(1):112. PubMed ID: 37784176
[TBL] [Abstract] [Full Text] [Related]
3. TMED2 Induces Cisplatin Resistance in breast cancer via Targeting the KEAP1-nrf2 Pathway.
Liang C; Zhang HY; Wang YQ; Yang LA; Du YS; Luo Y; Zhang TC; Xu Y
Curr Med Sci; 2023 Oct; 43(5):1023-1032. PubMed ID: 37615927
[TBL] [Abstract] [Full Text] [Related]
4. STAT3 inhibition enhances gemcitabine sensitivity in pancreatic cancer by suppressing EMT, immune escape and inducing oxidative stress damage.
Guo H; Hu Z; Yang X; Yuan Z; Gao Y; Chen J; Xie L; Chen C; Guo Y; Bai Y
Int Immunopharmacol; 2023 Oct; 123():110709. PubMed ID: 37515849
[TBL] [Abstract] [Full Text] [Related]
5. Natural Compounds, Optimal Combination of Brusatol and Polydatin Promote Anti-Tumor Effect in breast cancer by Targeting nrf2 Signaling Pathway.
Li J; Zhang J; Zhu Y; Afolabi LO; Chen L; Feng X
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175972
[TBL] [Abstract] [Full Text] [Related]
6. Cuproptosis Combined with lncRNAs Predicts the prognosis and Immune Microenvironment of breast cancer.
Zhang L; Zhang Y; Bao J; Gao W; Wang D; Pan H
Comput Math Methods Med; 2022; 2022():5422698. PubMed ID: 36213577
[TBL] [Abstract] [Full Text] [Related]
7. Myricetin-induced apoptosis in triple-negative breast cancer cells through inhibition of the PI3K/Akt/mTOR pathway.
Sharma P; Khan MA; Najmi AK; Chaturvedi S; Akhtar M
Med Oncol; 2022 Oct; 39(12):248. PubMed ID: 36209343
[TBL] [Abstract] [Full Text] [Related]
8. nrf2 drives an oxidative stress response predictive of breast cancer.
Wolowczyk C; Neckmann U; Aure MR; Hall M; Johannessen B; Zhao S; Skotheim RI; Andersen SB; Zwiggelaar R; Steigedal TS; Lingjærde OC; Sahlberg KK; Almaas E; Bjørkøy G
Free Radic Biol Med; 2022 May; 184():170-184. PubMed ID: 35381325
[TBL] [Abstract] [Full Text] [Related]
9. Machine Learning Identifies Pan-cancer Landscape of nrf2 Oxidative Stress Response Pathway-Related Genes.
Li N; Zhan X
Oxid Med Cell Longev; 2022; 2022():8450087. PubMed ID: 35242279
[TBL] [Abstract] [Full Text] [Related]
10. Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNBC) progression and M2 macrophage functions under the oncogenic stress.
Al Haq AT; Tseng HY; Chen LM; Wang CC; Hsu HL
Cell Death Dis; 2022 Jan; 13(1):49. PubMed ID: 35017469
[TBL] [Abstract] [Full Text] [Related]
11. The role of functional polymorphisms in oxidative stress-related genes on early-stage breast cancer survival.
Korobeinikova E; Ugenskiene R; Insodaite R; Rudzianskas V; Gudaitiene J; Juozaityte E
Int J Biol Markers; 2021 Jun; 36(2):14-21. PubMed ID: 33885357
[TBL] [Abstract] [Full Text] [Related]
12. sMicroRNA-28-5p acts as a metastasis suppressor in gastric cancer by targeting nrf2.
Yue CF; Li LS; Ai L; Deng JK; Guo YM
Exp Cell Res; 2021 May; 402(2):112553. PubMed ID: 33737068
[TBL] [Abstract] [Full Text] [Related]
13. Pan-cancer Multiomics Analysis of TC2N Gene Suggests its Important Role(s) in Tumourigenesis of Many cancers.
Qureshi MA; Khan S; Tauheed MS; Syed SA; Ujjan ID; Lail A; Sharafat S
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3199-3209. PubMed ID: 33247676
[TBL] [Abstract] [Full Text] [Related]
14. nrf2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism.
Fox DB; Garcia NMG; McKinney BJ; Lupo R; Noteware LC; Newcomb R; Liu J; Locasale JW; Hirschey MD; Alvarez JV
Nat Metab; 2020 Apr; 2(4):318-334. PubMed ID: 32691018
[TBL] [Abstract] [Full Text] [Related]
15. H-Ras induces nrf2-Pin1 interaction: Implications for breast cancer progression.
Saeidi S; Kim SJ; Han HJ; Kim SH; Zheng J; Lee HB; Han W; Noh DY; Na HK; Surh YJ
Toxicol Appl Pharmacol; 2020 Sep; 402():115121. PubMed ID: 32621833
[TBL] [Abstract] [Full Text] [Related]
16. NR5A2 synergizes with NCOA3 to induce breast cancer resistance to BET inhibitor by upregulating nrf2 to attenuate ferroptosis.
Qiao J; Chen Y; Mi Y; Jin H; Huang T; Liu L; Gong L; Wang L; Wang Q; Zou Z
Biochem Biophys Res Commun; 2020 Sep; 530(2):402-409. PubMed ID: 32536370
[TBL] [Abstract] [Full Text] [Related]
17. Research Progress on Long Non-coding RNAs and Drug Resistance of breast cancer.
Zhang X; Yang H
Clin Breast Cancer; 2020 Aug; 20(4):275-282. PubMed ID: 32414649
[TBL] [Abstract] [Full Text] [Related]
18. The prognostic value of nrf2 in breast cancer patients: a systematic review with meta-analysis.
Almeida M; Soares M; Ramalhinho AC; Moutinho JF; Breitenfeld L; Pereira L
Breast Cancer Res Treat; 2020 Feb; 179(3):523-532. PubMed ID: 31745730
[TBL] [Abstract] [Full Text] [Related]
19. Cullin 3 overexpression inhibits lung cancer metastasis and is associated with survival of lung adenocarcinoma.
Zhou J; Zhang S; Xu Y; Ye W; Li Z; Chen Z; He Z
Clin Exp Metastasis; 2020 Feb; 37(1):115-124. PubMed ID: 31463796
[TBL] [Abstract] [Full Text] [Related]
20. Lipid Profile and Aquaporin Expression under Oxidative Stress in breast cancer Cells of Different Malignancies.
Rodrigues C; Milkovic L; Bujak IT; Tomljanovic M; Soveral G; Cipak Gasparovic A
Oxid Med Cell Longev; 2019; 2019():2061830. PubMed ID: 31379986
[TBL] [Abstract] [Full Text] [Related]
[Next]
